Matthew Spite

Author PubWeight™ 17.74^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.	J Exp Med	2008	3.35
2	Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.	FASEB J	2011	1.72
3	Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.	J Immunol	2011	1.52
4	Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.	Am J Pathol	2010	1.47
5	Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.	Circ Res	2009	1.32
6	Proresolution therapy for the treatment of delayed healing of diabetic wounds.	Diabetes	2012	1.27
7	Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.	Annu Rev Nutr	2012	1.24
8	Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.	Circ Res	2012	1.11
9	Aldose reductase-catalyzed reduction of aldehyde phospholipids.	J Biol Chem	2004	1.10
10	Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production.	J Immunol	2013	0.88
11	Proresolving lipid mediators and diabetic wound healing.	Curr Opin Endocrinol Diabetes Obes	2012	0.83
12	Recent advances in the role of immunity in atherosclerosis.	Circ Res	2013	0.81
13	MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.	J Clin Invest	2017	0.77
14	Lipid signatures of unstable atheromas: fossils or a step toward personalized lipidomics-metabolomics?	Circ Cardiovasc Genet	2011	0.76